MDT Earnings
Upcoming earnings date and last 8 quarters of EPS surprise.
Next Earnings
EPS Surprise — Last 8 Quarters
Quarterly Detail
| Quarter | Report Date | Est EPS | Actual EPS | Surprise % | Result |
|---|---|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | 1.34 | 1.36 | +1.86% | Beat |
| Q3 2025 | Nov 18, 2025 | 1.31 | 1.36 | +3.49% | Beat |
| Q2 2025 | Aug 19, 2025 | 1.23 | 1.26 | +2.54% | Beat |
| Q1 2025 | May 21, 2025 | 1.58 | 1.62 | +2.69% | Beat |
| Q4 2024 | Feb 18, 2025 | 1.36 | 1.39 | +2.24% | Beat |
| Q3 2024 | Nov 19, 2024 | 1.25 | 1.26 | +0.85% | Inline |
| Q2 2024 | Aug 20, 2024 | 1.20 | 1.23 | +2.65% | Beat |
| Q1 2024 | May 23, 2024 | 1.45 | 1.46 | +0.70% | Inline |
Recent Guidance Mentions (8-K)
- Mar 24, 2026 · 8-K
6, Medtronic announced that it now expects non-GAAP earnings per share (EPS) for fiscal year 2026 to be in the range of $5.50 to $5.54, a revision from the Q3 earnings call EPS guidance of $5.62 to $5.66. The Company’s guidance for fiscal year 2027 of high single-digit EPS growth remains unchanged, and is based upon the prior guidance from the Q3 earnings call
View 8-K filing → - Mar 24, 2026 · 8-K
of the information contained in this filing, including to reflect future events or circumstances. Non-GAAP financial measures This presentation contains financial measures and guidance which are considered “non-GAAP” financial measures under applicable SEC rules and regulations. Medtronic management believes that non-GAAP financial measures provide informatio
View 8-K filing → - Mar 24, 2026 · 8-K
r gains that would be recorded as non-GAAP adjustments to earnings during the fiscal year. Medtronic does not attempt to provide reconciliations of forward-looking non-GAAP EPS guidance to projected GAAP EPS guidance because the combined impact and timing of recognition of these potential charges or gains is inherently uncertain and difficult to predict and is
View 8-K filing →
Data updated May 25, 2026 · source: Yahoo Finance via yfinance